Special holiday promotion: on June 1 and 2, receive 10% off the entire product range!
Getrufline — a truffle that stands for your health.
Subscribe to mailing and get the latest news and discounts of our store.>
Updated Edition Released: «Complex Application of Peptides Products — 2025»
Now available for the European market!
Peptides announces the release of the updated and expanded 2025 edition of the guidebook «Complex Application of Peptides Products», specially adapted for practical use across the European market.
The new edition is published in English and offers:
- Revised protocols and application schemes for both peptide and non-peptide bioregulators, based on the latest clinical data and research;
- Full integration of the expanded 2024–2025 product portfolio, including newly developed formulations and delivery forms;
- Detailed, condition-specific recommendations covering the prevention and support of over 40 common health concerns — from chronic inflammatory diseases to age-related and metabolic disorders.
The electronic version is already available for professionals and customers.
A printed version will be available for purchase later this year.
Translations into other key European languages are currently in progress and will be released in the
near
future to ensure broader accessibility.
This edition is an essential tool for healthcare professionals, nutritionists, preventive medicine specialists, consultants, and all users of Peptides products aiming to maintain health, longevity, and wellbeing through scientifically grounded protocols.
Wishing you good health, sunny spirits, and a wonderful holiday surrounded by your loved ones! Please note our online store’s holiday schedule:
We are always delighted to share new informational products with you. We present methodological guidelines developed by Peptides Company experts: "Enhancing the Reserve Capacity of the Body in Fitness Club Members and Athletes Using Peptide and Non-Peptide Bioregulators"
Kidney diseases are a global health challenge, affecting 10-20% of the population and significantly impacting quality of life. Therefore, our new research article in the SIC project focuses on the use of peptide bioregulators (such as Pielotax, Ovagen, and Renefort) in the prevention and treatment of kidney pathologies.
